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Social Science and the Study of
Emerging Infectious Diseases
Topics related to emerging and reemerging in-
fectious diseases attracted a considerable audi-
ence at the annual meeting of the American
Anthropological Association, November 15–19,
1995, in Washington, D.C. The meeting had a
separate session entitled “Emerging and Ree-
merging Infectious Diseases: Biocultural and So-
ciocultural Approaches.”
The session brought together anthropologists
interested in and working on emerging infectious
diseases from various subdisciplinary perspec-
tives. Presentations were made on the following
subjects: outline of a research agenda, deforesta-
tion and the emergence of infectious diseases in
the rain forests of Papua-New Guinea, the cholera
epidemic in Latin America, evolutionary aspects
of emergent infections, societal impacts of the test
for acquired immunodeficiency syndrome, compli-
ance and iatrogenesis in tuberculosis treatment in
the United States, patchwork policies that affect
long-term treatment of tuberculosis in Nepal and
Uganda, the reemergence of schistosomiasis in
Egypt, dengue control in Latin America, cultural
and political ecologic models of emergent infec-
tions, and the politics of leprosy eradication. Ab-
stracts are available from the conference
organizers, listed below.
Anthropologists interested in international
health and the social science aspects of infectious
diseases are organized in a working group called
the International Health and Infectious Disease
Study Group of the Society of Medical Anthropol-
ogy (American Anthropological Association). Re-
quests to subscribe to this group’s newsletter can
be sent to
Johannes Sommerfeld
Harvard Institute for International Development
Cambridge, Massachusetts, USA
Phone: 617-495-9791
E-mail: jsommerf@hiid.harvard.edu
Sandra Lane
Case Western Reserve University
Cleveland, Ohio, USA
E-mail: sxl45@po.cwru.edu
WHO Establishes New
Rapid-Response Unit for Emerging
Infectious Diseases
The World Health Organization (WHO) has
established a new rapid-response unit to control
and prevent the growing incidence of new and
reemerging diseases worldwide. The unit’s focus
will be improved containment of disease out-
breaks, such as that caused by the deadly Ebola
virus, which struck Zaire in 1995.
The WHO unit will be called the Division of
Emerging Viral and Bacterial Diseases Surveil-
lance and Control (EMC). It will be capable of
mobilizing staff from WHO headquarters in Ge-
neva and from the organization’s regional offices.
In addition to mobilizing WHO’s own technical
staff and expertise, EMC will coordinate the ac-
tivities of the agency’s traditional partners, for
example, its international network of collaborat-
ing centers, bilateral donors, expert advisers, and
nongovernmental organizations.
Teams equipped to implement epidemic control
measures will be placed on-site within 24 hours’
notification of an outbreak. This strategy, when
implemented in Zaire, not only rapidly contained
the recent Ebola outbreak but also prevented its
spread to Kinshasa, the capital city of 2 million.
Among EMC’s goals are 1) to strengthen local
surveillance and disease control so that countries
can develop the early warning systems needed to
detect emerging or reemerging diseases through
innovative field epidemiology and public health
laboratory training programs and 2) to continue
WHO’s activities in developing a network of public
health laboratories to strengthen regional and
international collaboration in outbreak detection
and control.
EMC will continue to expand WHO’s network—
termed WHONET—that detects and monitors an-
tibiotic resistance worldwide. WHO will use the
information collected to continue to advocate
research and development of new antibiotics to
replace those that are no longer effective.
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Philippe Stroot
Health Communications and Public Relations
World Health Organization
Geneva, Switzerland
Phone: 41-22-791-2535
Fax: 41-22-791-4858
Rotavirus Vaccine Workshop Held
More than 125 participants from at least 15
countries attended the Fifth Rotavirus Vaccine
Workshop at the Centers for Disease Control and
Prevention (CDC) in Atlanta, Georgia, October
16-17, 1995.
Rotavirus has emerged as the most important
cause of severe diarrhea in children worldwide. It
is a problem not only in developing countries,
where it kills an estimated 870,000 children each
year, but also in the United States, where it re-
mains the most important single cause of hospi-
talization or clinic visits for childhood diarrhea.
Moreover, although studies from many coun-
tries indicate that only four serotypes are pre-
dominant worldwide, some strains at every site
studied cannot be serotyped. In some countries
such as India, the diversity of strains is extensive.
Further studies are needed to define the extent of
cross-protection against these strains that is in-
duced by the vaccine to determine whether addi-
tional antigens need to be included in vaccines for
such areas.
This workshop included sessions on epidemiol-
ogy, virology, pathogenesis and immunity, and vac-
cines currently being tested. Each session had
numerous presentations by leaders in the field of
rotavirus research. Researchers reported that sev-
eral live oral rotavirus vaccines, based on animal
strains of rotavirus combined with reassortant
strains, have been tested in field trials in children.
These appear to protect American children against
rotavirus and are more efficacious against severe
disease. These vaccines like natural protection,
are not 100% protective so many investigators are
exploring alternative approaches to vaccines such
as the use of virus-like particles, native DNA, and
microencapsulation of antigens.
No published volume of proceedings from the
workshop is planned, but a supplemental issue of
the Journal of Infectious Diseases scheduled for
early 1996 will contain papers from the meeting.
The workshop was held under the auspices of
the National Institutes of Health, Emory Univer-
sity School of Medicine, and the World Health
Organization.
For further information, contact
Roger I. Glass
Global Program for Vaccines and Immunizations
World Health Organization
Geneva, Switzerland
Phone: 41-22-791-2698/2681
Fax: 41-22-791-4860
International Conference Addresses
Preparedness for Emerging Strains
of Pandemic Influenza
An international meeting on pertinent issues
related to recognizing, identifying, and controlling
newly emerging strains of pandemic influenza
was held in Bethesda, Maryland, December 11–
13, 1995. The conference, “Pandemic Influenza:
Confronting a Reemergent Threat,” was spon-
sored by the National Institutes of Health, the
University of Michigan, the Centers for Disease
Control and Prevention, the Food and Drug Ad-
ministration, the U.S.-Japan Cooperative Medical
Science Program, and the World Health
Organization.
Epidemic strains of influenza cause infections
almost every year throughout the world because
of continuous minor genetic changes in the virus.
However, periodically a major change occurs, such
as reassortment between mammalian and avian
strains of the virus. These pandemic strains are
novel to the human immune system and, there-
fore, can cause substantial disease worldwide. The
conference concentrated on issues that would be
crucial to controlling an influenza pandemic.
Plenary and workshop sessions examined the
following topics: Can pandemics be predicted?
What are the specific approaches for pandemic
control? What are the advantages and limitations
of vaccines and antiviral agents? The workshops
also focused on factors contributing to the emer-
gence of pandemic strains and various aspects of
surveillance, such as the adequacy of current
global surveillance structure for early identifica-
tion of a pandemic strain, the use of virologic and
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